These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 20097316)
41. Molecular evidence of anaplastic transformation in coexisting well-differentiated and anaplastic carcinomas of the thyroid. Hunt JL; Tometsko M; LiVolsi VA; Swalsky P; Finkelstein SD; Barnes EL Am J Surg Pathol; 2003 Dec; 27(12):1559-64. PubMed ID: 14657716 [TBL] [Abstract][Full Text] [Related]
42. Mechanisms and pathogenesis of thyroid cancer in animals and man. Williams ED Mutat Res; 1995 Dec; 333(1-2):123-9. PubMed ID: 8538619 [TBL] [Abstract][Full Text] [Related]
45. Thyroid tumorigenesis. Williams ED Horm Res; 1994; 42(1-2):31-4. PubMed ID: 7959631 [TBL] [Abstract][Full Text] [Related]
46. Differential oncogenic expression in thyroid follicular and Hürthle cell carcinomas. Masood S; Auguste LJ; Westerband A; Belluco C; Valderama E; Attie J Am J Surg; 1993 Oct; 166(4):366-8. PubMed ID: 8214294 [TBL] [Abstract][Full Text] [Related]
47. Thyroid Follicular Epithelial Cell-Derived Cancer: New Approaches and Treatment Strategies. Bolin J J Nucl Med Technol; 2021 Sep; 49(3):199-208. PubMed ID: 34244225 [TBL] [Abstract][Full Text] [Related]
48. [Molecular pathogenesis of thyroid tumors]. Karger S; Krause K; Führer D Dtsch Med Wochenschr; 2006 Jul; 131(30):1671-4. PubMed ID: 16850385 [No Abstract] [Full Text] [Related]
49. [Growth and invasion of differentiated thyroid gland carcinoma: importance of signal transduction]. Hölting T; Duh OY; Clark OH; Herfarth C Langenbecks Arch Chir; 1995; 380(2):96-101. PubMed ID: 7760657 [TBL] [Abstract][Full Text] [Related]
50. MicroRNA role in thyroid cancer pathogenesis. Zhang X; Mao H; Lv Z Front Biosci (Landmark Ed); 2013 Jan; 18(2):734-9. PubMed ID: 23276957 [TBL] [Abstract][Full Text] [Related]
51. Point mutation in GRIM-19: a new genetic lesion in Hurthle cell thyroid carcinomas. Fusco A; Viglietto G; Santoro M Br J Cancer; 2005 May; 92(10):1817-8. PubMed ID: 15900303 [No Abstract] [Full Text] [Related]
53. Pituitary metastases from the oncocytic variant of follicular thyroid carcinoma: a case report and diagnostic dilemmas. Matyja E; Zieliński G; Witek P; Kamiński G; Grajkowska W; Maksymowicz M Folia Neuropathol; 2013; 51(3):261-8. PubMed ID: 24114644 [TBL] [Abstract][Full Text] [Related]
54. Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB. Aasland R; Lillehaug JR; Male R; Jøsendal O; Varhaug JE; Kleppe K Br J Cancer; 1988 Apr; 57(4):358-63. PubMed ID: 3390372 [TBL] [Abstract][Full Text] [Related]
55. Familial non-medullary thyroid cancer in Iceland. Hrafnkelsson J; Tulinius H; Jónasson JG; Sigvaldason H J Med Genet; 2001 Mar; 38(3):189-91. PubMed ID: 11303513 [No Abstract] [Full Text] [Related]
56. Classification of follicular cell-derived thyroid cancer by global RNA profiling. Rossing M J Mol Endocrinol; 2013 Apr; 50(2):R39-51. PubMed ID: 23355745 [TBL] [Abstract][Full Text] [Related]
57. Recent advances in cytometry, cytogenetics and molecular genetics of thyroid tumours and tumour-like lesions. Soares P; Sobrinho-Simões M Pathol Res Pract; 1995 May; 191(4):304-17. PubMed ID: 7479347 [TBL] [Abstract][Full Text] [Related]
58. Towards understanding the molecular basis of thyroid cancer. Farid NR Ann Saudi Med; 1995 May; 15(3):252-75. PubMed ID: 17590579 [TBL] [Abstract][Full Text] [Related]
59. Thyroid Growth and Cancer. Williams D Eur Thyroid J; 2015 Sep; 4(3):164-73. PubMed ID: 26558233 [TBL] [Abstract][Full Text] [Related]